Gene Therapy Media Market Size, Share, Trends, & Industry Analysis Report By Product (Specialty Media, Serum-free Media, Classical Media, Other Products), By Vector Type, By End User, and By Region – Market Forecast, 2025–2034
Description
The gene therapy media market size is expected to reach USD 2,001.61 million by 2034, according to a new study by Polaris Market Research. The report “Gene Therapy Media Market Share, Size, Trends, Industry Analysis Report: By Product, By Vector Type, By End User, and By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The gene therapy media market offers solutions for supporting viral and non-viral vector production, cell culture, and gene therapy manufacturing, including specialty media, serum-free media, and classical media for optimized cell growth, transfection efficiency and reproducible therapeutic outcomes.
Request a free sample copy or read the full market insights - gene therapy media market Report
Market growth is driven by rising demand for gene therapies in rare and chronic diseases. In addition, expansion of cell and gene therapy manufacturing facilities and adoption of scalable, high-quality media solutions are enhancing vector production efficiency and overall treatment effectiveness.
Gene Therapy Media Market Report Highlights
Based on product, specialty media dominated in 2024 due to high adoption in viral and non-viral vector production.
In terms of vector type, AAV production dominated in 2024, driven by widespread application in rare and chronic disease therapies.
Based on end user, pharmaceutical and biotechnology companies dominated in 2024 due to large-scale manufacturing and high R&D investments.
North America dominated the global market in 2024, fueled by advanced gene therapy infrastructure and high R&D investment.
Asia Pacific is projected to record the fastest growth, driven by expanding manufacturing facilities and growing awareness of gene therapies.
Key players in the global market include FUJIFILM Biosciences, Lonza Group AG, IQVIA Inc., Novartis AG, Nucleus Biologics, Sartorius AG, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Amsbio, Cencora, Inc., ElevateBio, Bayer AG, and AstraZeneca.
Polaris Market Research has segmented the market report based on product, vector type, end user, and region:
By Product (Revenue, USD Million, 2020–2034)
Specialty Media
Serum-free Media
Classical Media
Other Products
By Vector Type (Revenue, USD Million, 2020–2034)
AAV Production
LV Production
Other Vectors
By End User (Revenue, USD Million, 2020–2034)
Pharmaceutical and Biotechnology Companies
Contract Development & Manufacturing Organizations (CDMOs) & CROs
Research and Academic Institutes
By Region (Revenue, USD Million, 2020–2034)
North America
The U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Netherland
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Australia
Rest of Asia Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Latin America
Saudi Arabia
UAE
South Africa
Israel
Rest of South Africa
The gene therapy media market offers solutions for supporting viral and non-viral vector production, cell culture, and gene therapy manufacturing, including specialty media, serum-free media, and classical media for optimized cell growth, transfection efficiency and reproducible therapeutic outcomes.
Request a free sample copy or read the full market insights - gene therapy media market Report
Market growth is driven by rising demand for gene therapies in rare and chronic diseases. In addition, expansion of cell and gene therapy manufacturing facilities and adoption of scalable, high-quality media solutions are enhancing vector production efficiency and overall treatment effectiveness.
Gene Therapy Media Market Report Highlights
Based on product, specialty media dominated in 2024 due to high adoption in viral and non-viral vector production.
In terms of vector type, AAV production dominated in 2024, driven by widespread application in rare and chronic disease therapies.
Based on end user, pharmaceutical and biotechnology companies dominated in 2024 due to large-scale manufacturing and high R&D investments.
North America dominated the global market in 2024, fueled by advanced gene therapy infrastructure and high R&D investment.
Asia Pacific is projected to record the fastest growth, driven by expanding manufacturing facilities and growing awareness of gene therapies.
Key players in the global market include FUJIFILM Biosciences, Lonza Group AG, IQVIA Inc., Novartis AG, Nucleus Biologics, Sartorius AG, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Amsbio, Cencora, Inc., ElevateBio, Bayer AG, and AstraZeneca.
Polaris Market Research has segmented the market report based on product, vector type, end user, and region:
By Product (Revenue, USD Million, 2020–2034)
Specialty Media
Serum-free Media
Classical Media
Other Products
By Vector Type (Revenue, USD Million, 2020–2034)
AAV Production
LV Production
Other Vectors
By End User (Revenue, USD Million, 2020–2034)
Pharmaceutical and Biotechnology Companies
Contract Development & Manufacturing Organizations (CDMOs) & CROs
Research and Academic Institutes
By Region (Revenue, USD Million, 2020–2034)
North America
The U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Netherland
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Australia
Rest of Asia Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Latin America
Saudi Arabia
UAE
South Africa
Israel
Rest of South Africa
Table of Contents
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Gene Therapy Media Market Insights
- 4.1. Gene Therapy Media Market – Market Snapshot
- 4.2. Gene Therapy Media Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing demand for gene therapy products in rare and chronic diseases
- 4.2.1.2. Growth of cell and gene therapy manufacturing facilities worldwide
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High cost of specialized media and stringent quality requirements
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Gene Therapy Media Market Trends
- 4.6. Value Chain Analysis
- 5. Global Gene Therapy Media Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 5.3. Specialty Media
- 5.3.1. Global Gene Therapy Media Market, by Specialty Media, by Region, 2020-2034 (USD Million)
- 5.4. Serum-free Media
- 5.4.1. Global Gene Therapy Media Market, by Serum-free Media, by Region, 2020-2034 (USD Million)
- 5.5. Classical Media
- 5.5.1. Global Gene Therapy Media Market, by Classical Media, by Region, 2020-2034 (USD Million)
- 5.6. Other Products
- 5.6.1. Global Gene Therapy Media Market, by Other Products, by Region, 2020-2034 (USD Million)
- 6. Global Gene Therapy Media Market, by Vector Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 6.3. AAV Production
- 6.3.1. Global Gene Therapy Media Market, by AAV Production, by Region, 2020-2034 (USD Million)
- 6.4. LV Production
- 6.4.1. Global Gene Therapy Media Market, by LV Production, by Region, 2020-2034 (USD Million)
- 6.5. Other Vectors
- 6.5.1. Global Gene Therapy Media Market, by Other Vectors, by Region, 2020-2034 (USD Million)
- 7. Global Gene Therapy Media Market, by End User
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 7.3. Pharmaceutical and Biotechnology Companies
- 7.3.1. Global Gene Therapy Media Market, by Pharmaceutical and Biotechnology Companies, by Region, 2020-2034 (USD Million)
- 7.4. Contract Development & Manufacturing Organizations (CDMOs) & CROs
- 7.4.1. Global Gene Therapy Media Market, by Contract Development & Manufacturing Organizations (CDMOs) & CROs, by Region, 2020-2034 (USD Million)
- 7.5. Research and Academic Institutes
- 7.5.1. Global Gene Therapy Media Market, by Research and Academic Institutes, by Region, 2020-2034 (USD Million)
- 8. Global Gene Therapy Media Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Gene Therapy Media Market Assessment, By Geography, 2020-2034 (USD Million)
- 8.3. Gene Therapy Media Market – North America
- 8.3.1. North America: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.3.2. North America: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.3.3. North America: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.3.4. Gene Therapy Media Market – U.S.
- 8.3.4.1. U.S.: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.3.4.2. U.S.: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.3.4.3. U.S.: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.3.5. Gene Therapy Media Market – Canada
- 8.3.5.1. Canada: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.3.5.2. Canada: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.3.5.3. Canada: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.4. Gene Therapy Media Market – Europe
- 8.4.1. Europe: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.4.2. Europe: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.4.3. Europe: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.4.4. Gene Therapy Media Market – UK
- 8.4.4.1. UK: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.4.4.2. UK: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.4.4.3. UK: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.4.5. Gene Therapy Media Market – France
- 8.4.5.1. France: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.4.5.2. France: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.4.5.3. France: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.4.6. Gene Therapy Media Market – Germany
- 8.4.6.1. Germany: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.4.6.2. Germany: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.4.6.3. Germany: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.4.7. Gene Therapy Media Market – Italy
- 8.4.7.1. Italy: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.4.7.2. Italy: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.4.7.3. Italy: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.4.8. Gene Therapy Media Market – Spain
- 8.4.8.1. Spain: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.4.8.2. Spain: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.4.8.3. Spain: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.4.9. Gene Therapy Media Market – Netherlands
- 8.4.9.1. Netherlands: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.4.9.2. Netherlands: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.4.9.3. Netherlands: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.4.10. Gene Therapy Media Market – Russia
- 8.4.10.1. Russia: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.4.10.2. Russia: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.4.10.3. Russia: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.4.11. Gene Therapy Media Market – Rest of Europe
- 8.4.11.1. Rest of Europe: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.4.11.2. Rest of Europe: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.4.11.3. Rest of Europe: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.5. Gene Therapy Media Market – Asia Pacific
- 8.5.1. Asia Pacific: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.5.2. Asia Pacific: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.5.3. Asia Pacific: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.5.4. Gene Therapy Media Market – China
- 8.5.4.1. China: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.5.4.2. China: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.5.4.3. China: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.5.5. Gene Therapy Media Market – India
- 8.5.5.1. India: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.5.5.2. India: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.5.5.3. India: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.5.6. Gene Therapy Media Market – Malaysia
- 8.5.6.1. Malaysia: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.5.6.2. Malaysia: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.5.6.3. Malaysia: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.5.7. Gene Therapy Media Market – Japan
- 8.5.7.1. Japan: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.5.7.2. Japan: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.5.7.3. Japan: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.5.8. Gene Therapy Media Market – Indonesia
- 8.5.8.1. Indonesia: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.5.8.2. Indonesia: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.5.8.3. Indonesia: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.5.9. Gene Therapy Media Market – South Korea
- 8.5.9.1. South Korea: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.5.9.2. South Korea: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.5.9.3. South Korea: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.5.10. Gene Therapy Media Market – Australia
- 8.5.10.1. Australia: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.5.10.2. Australia: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.5.10.3. Australia: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.5.11. Gene Therapy Media Market – Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.5.11.2. Rest of Asia Pacific: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.5.11.3. Rest of Asia Pacific: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.6. Gene Therapy Media Market – Middle East & Africa
- 8.6.1. Middle East & Africa: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.6.2. Middle East & Africa: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.6.3. Middle East & Africa: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.6.4. Gene Therapy Media Market – Saudi Arabia
- 8.6.4.1. Saudi Arabia: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.6.4.2. Saudi Arabia: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.6.4.3. Saudi Arabia: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.6.5. Gene Therapy Media Market – UAE
- 8.6.5.1. UAE: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.6.5.2. UAE: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.6.5.3. UAE: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.6.6. Gene Therapy Media Market – Israel
- 8.6.6.1. Israel: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.6.6.2. Israel: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.6.6.3. Israel: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.6.7. Gene Therapy Media Market – South Africa
- 8.6.7.1. South Africa: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.6.7.2. South Africa: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.6.7.3. South Africa: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.6.8. Gene Therapy Media Market – Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.6.8.2. Rest of Middle East & Africa: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.6.8.3. Rest of Middle East & Africa: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.7. Gene Therapy Media Market – Latin America
- 8.7.1. Latin America: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.7.2. Latin America: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.7.3. Latin America: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.7.4. Gene Therapy Media Market – Mexico
- 8.7.4.1. Mexico: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.7.4.2. Mexico: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.7.4.3. Mexico: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.7.5. Gene Therapy Media Market – Brazil
- 8.7.5.1. Brazil: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.7.5.2. Brazil: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.7.5.3. Brazil: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.7.6. Gene Therapy Media Market – Argentina
- 8.7.6.1. Argentina: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.7.6.2. Argentina: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.7.6.3. Argentina: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 8.7.7. Gene Therapy Media Market – Rest of Latin America
- 8.7.7.1. Rest of Latin America: Gene Therapy Media Market, by Product, 2020-2034 (USD Million)
- 8.7.7.2. Rest of Latin America: Gene Therapy Media Market, by Vector Type, 2020-2034 (USD Million)
- 8.7.7.3. Rest of Latin America: Gene Therapy Media Market, by End User, 2020-2034 (USD Million)
- 9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
- 10. Company Profiles
- 10.1. Agilent Technologies, Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Amsbio
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. AstraZeneca
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Bayer AG
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Cencora, Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Danaher Corporation
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. ElevateBio
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. FUJIFILM Biosciences
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. IQVIA Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Lonza Group AG
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Novartis AG
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Nucleus Biologics
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Sartorius AG
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. Thermo Fisher Scientific Inc.
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
